Cleveland BioLabs
2
19M
1
0.11
0.50
- Areas of investment
Summary
Cleveland BioLabs appeared to be the Corporate Investor, which was created in 2003. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Buffalo.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Cleveland BioLabs, startups are often financed by RUSNANO. The meaningful sponsors for the fund in investment in the same round are RUSNANO. In the next rounds fund is usually obtained by RUSNANO.
Among the most popular portfolio startups of the fund, we may highlight Panacela Labs. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Medical, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The important activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 0.11
- Follow on index
- 0.50
- Investments by industry
- Biotechnology (2)
- Medical (2)
- Health Care (2)
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Panacela Labs | 24 Dec 2015 | Biotechnology, Health Care, Medical | Early Stage Venture | 2M | United States, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.